<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction Schema extraction-schema-1 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extraction Schema Details for extraction-schema-1</h1>

        <div class="section">
            <h2>Extraction Schema (General Information)</h2>
            <div class="info-section">
                <p><strong>Schema ID:</strong> extraction-schema-1</p>
                <p><strong>Extraction Query:</strong> Extract any mentions of driver alterations, oncogenic mutations, or genomic changes in lung adenocarcinoma, including both known drivers in RTK/RAS/RAF pathway and novel/rare drivers, especially those found in tumors lacking canonical driver mutations.</p>
            </div>
        </div>

        <div class="section">
            <h2>Extraction Schema (Details)</h2>
            <table>
                <thead>
                    <tr>
                        <th style="width: 20%;">Field Name</th>
                        <th style="width: 15%;">Type</th>
                        <th style="width: 65%;">Description</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>driver_alteration</strong></td>
                        <td>str</td>
                        <td>The specific genetic alteration, mutation, fusion, amplification, or other genomic change identified as a potential driver (e.g. 'EGFR L858R', 'KRAS G12C', 'ALK fusion', 'NF1 loss', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>alteration_type</strong></td>
                        <td>str</td>
                        <td>The type of alteration (e.g. 'point mutation', 'gene fusion', 'amplification', 'deletion', 'loss of function', 'copy number alteration', 'epigenetic change', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>gene_or_pathway</strong></td>
                        <td>str</td>
                        <td>The gene(s) or pathway involved in the alteration</td>
                    </tr>
                    <tr>
                        <td><strong>is_rtk_ras_raf_pathway</strong></td>
                        <td>bool</td>
                        <td>Is this alteration in the canonical RTK/RAS/RAF pathway? (true for known drivers like EGFR, KRAS, ALK, ROS1, BRAF, etc.; false for alterations outside this pathway; null if unclear)</td>
                    </tr>
                    <tr>
                        <td><strong>frequency_in_luad</strong></td>
                        <td>str</td>
                        <td>What is the frequency/prevalence of this alteration in lung adenocarcinoma? (e.g. '15%', '3-5%', 'rare <1%', etc. Include exact numbers if available, null if not reported)</td>
                    </tr>
                    <tr>
                        <td><strong>frequency_in_driver_negative</strong></td>
                        <td>str</td>
                        <td>What is the frequency of this alteration specifically in driver-negative or pan-negative lung adenocarcinomas (i.e., those lacking known RTK/RAS/RAF drivers)? (numerical with units, null if not reported)</td>
                    </tr>
                    <tr>
                        <td><strong>evidence_type</strong></td>
                        <td>str</td>
                        <td>What type of evidence supports this being a driver? (e.g. 'genomic profiling', 'functional studies', 'response to targeted therapy', 'mouse models', 'co-occurrence/mutual exclusivity analysis', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>functional_evidence</strong></td>
                        <td>str</td>
                        <td>Describe any functional or mechanistic evidence that this alteration drives tumor growth (e.g. 'increases cell proliferation in vitro', 'tumorigenic in mouse models', 'activates MAPK signaling', etc. null if not reported)</td>
                    </tr>
                    <tr>
                        <td><strong>clinical_associations</strong></td>
                        <td>str</td>
                        <td>Any clinical or pathological features associated with this driver (e.g. 'found in never-smokers', 'associated with solid subtype', 'more common in smokers', 'co-occurs with TP53 mutations', etc. null if not reported)</td>
                    </tr>
                    <tr>
                        <td><strong>therapeutic_implications</strong></td>
                        <td>str</td>
                        <td>Are there therapeutic implications or targeted therapies for this alteration? (e.g. 'responsive to drug X', 'potential target for Y inhibitor', etc. null if not reported)</td>
                    </tr>
                    <tr>
                        <td><strong>study_cohort_size</strong></td>
                        <td>str</td>
                        <td>How many lung adenocarcinoma samples were analyzed in the study? (numerical, null if not reported)</td>
                    </tr>
                    <tr>
                        <td><strong>detection_method</strong></td>
                        <td>str</td>
                        <td>What methods were used to detect this alteration? (e.g. 'whole exome sequencing', 'RNA-seq', 'targeted panel sequencing', 'immunohistochemistry', etc.)</td>
                    </tr>
                    <tr>
                        <td><strong>novel_or_rare</strong></td>
                        <td>bool</td>
                        <td>Is this described as a novel, rare, or previously uncharacterized driver in lung adenocarcinoma? (true if novel/rare/emerging, false if well-established, null if unclear)</td>
                    </tr>
                </tbody>
            </table>
        </div>

    </div>
</body>
</html>